Lena Winestone, MD, assistant professor of pediatrics at the University of California, San Francisco, explains how her research into disparities in pediatric acute myeloid leukemia (AML) may help identify the cause of those disparities and how best to intervene in order to improve outcomes for these patients.
Lena Winestone, MD, assistant professor of pediatrics at the University of California, San Francisco, explains how her research into disparities in pediatric acute myeloid leukemia (AML) may help identify the cause of those disparities and how best to intervene in order to improve outcomes for these patients.
Transcript
How do we overcome the fact that neighborhood income or poverty level impacts treatment children with cancer receive?
Yeah, I think it's a great question, and obviously, the main goal of this work is to eventually allow for these disparities to be at least attenuated and ideally eliminated. I think that we're not at the point where we can really intervene on these findings yet, because we are really teasing apart the mechanisms or causes of the disparities that exist.
So, part of what I described as we're looking at, is it related to relapse? Is it related to the treatment-related toxicity? Is it related to the comorbidities that patients come in with? In addition, we're looking really closely at the timing. So, I mentioned that we looked at early mortality, but we're also looking at the timing of death about whether they occur sort of during that on therapy, while they're receiving chemotherapy, or in the after period, once they are off chemotherapy. And that'll help us to figure out where to target and interventions.
If it's something related to access to care, then for example, a health navigator may be part of the way to mitigate these effects. So, someone who can really assess the needs of a family and say, “Oh, they're really having insurance issues, let's help them with that piece,” or “They're really having transportation issues, let's help them with that piece.” And so, you could tailor the intervention to each individual and the specific needs that are sort of barriers to care for them.
Another alternative that one of my colleagues is investigating is actually addressing the concrete needs of families. So, for example, you don't have enough food to eat. And so that makes it really hard to take your medication. In the setting of pediatric AML that's less of an issue because all of the chemotherapy is administered in the hospital. But we do still think that things like nutritional status, potentially having an impact on outcome, both relapse and treatment-related mortality.
And so, thinking about both concrete interventions and more supportive interventions that can be tailored to families is definitely the goal of this research, ultimately.
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
BRCA-Like Classification May Be a Useful Biomarker for Olaparib Response in Ovarian Cancer
May 1st 2024Adding olaparib to maintenance therapy with bevacizumab was associated with significantly longer survival for patients with ovarian cancer whose tumors have a BRCA-like genomic profile, but not among those with non-BRCA-like tumors, a study found.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
AUA to Focus on Inclusive Care, Robotic Surgeries, and Future of Urology at 2024 Annual Meeting
May 1st 2024The American Urological Association (AUA) 2024 Annual Meeting will highlight the latest innovations and future trends in urology, featuring dynamic plenary sessions, educational opportunities for providers, and discussions on cutting-edge treatments and global health initiatives.
Read More
OptumRx’s Jon Mahrt Discusses “Irresponsible” Drug Pricing for Products With Multiple Indications
April 30th 2024When the same product comes to market with additional indications, irrational pricing decisions result in ever increasing prices instead of volume translating to lower costs, said Jon Mahrt, MBA, of OptumRX.
Read More